38,95 €
38,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
19 °P sammeln
38,95 €
38,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
19 °P sammeln
Als Download kaufen
38,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
19 °P sammeln
Jetzt verschenken
38,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
19 °P sammeln
  • Format: ePub

We live in a century of technological revolution and the birth of artificial intelligence. Like every other sphere of our life, diabetes-related technology is moving forward with lightning speed. New and improved insulin administration devices, increased capacity for monitoring one's blood glucose levels, and the ability to communicate directly with the device supplying insulin as well as with the patient and his/her healthcare provider have changed diabetes therapy forever. The problem is that diabetes-related technology is moving ahead much faster than physicians and other healthcare…mehr

  • Geräte: eReader
  • mit Kopierschutz
  • eBook Hilfe
  • Größe: 19.46MB
Produktbeschreibung
We live in a century of technological revolution and the birth of artificial intelligence. Like every other sphere of our life, diabetes-related technology is moving forward with lightning speed. New and improved insulin administration devices, increased capacity for monitoring one's blood glucose levels, and the ability to communicate directly with the device supplying insulin as well as with the patient and his/her healthcare provider have changed diabetes therapy forever.
The problem is that diabetes-related technology is moving ahead much faster than physicians and other healthcare professionals can incorporate these advances into our practices.
will consist of three parts:
Part I addresses the clinical science of diabetes pumps, continuous glucose monitoring and communication technology with numerous practical aspects.
Part III offers personal stories of healthcare providers who treat their own diabetes with modern diabetes technology. In particular, they will address how and why they decided to use this technology and the positive and negative aspects of their decision.

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, D ausgeliefert werden.

Autorenporträt
Boris Draznin, MD, PhD, is the Celeste and Jack Grynberg Professor of Medicine and Director of the Adult Diabetes Program at the University of Colorado School of Medicine. Dr. Draznin is an internationally known leader in the field of diabetes research and clinical practice. He served as Chair of the Professional Section Advisory Panel of the American Diabetes Association and President of the Western Association of Physicians.